Danaher Share Holder Equity 2012-2025 | DHR
Danaher share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Danaher share holder equity for the quarter ending December 31, 2025 was $51.080B, a 0.44% decline year-over-year.
- Danaher share holder equity for 2024 was $49.55B, a 7.37% decline from 2023.
- Danaher share holder equity for 2023 was $53.49B, a 6.79% increase from 2022.
- Danaher share holder equity for 2022 was $50.09B, a 10.88% increase from 2021.
|
Danaher Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $49,550 |
| 2023 | $53,490 |
| 2022 | $50,090 |
| 2021 | $45,177 |
| 2020 | $39,777 |
| 2019 | $30,282 |
| 2018 | $28,227 |
| 2017 | $26,368 |
| 2016 | $23,077 |
| 2015 | $23,764 |
| 2014 | $23,450 |
| 2013 | $22,451 |
| 2012 | $19,084 |
| 2011 | $16,972 |
|
Danaher Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $51,080 |
| 2025-06-30 | $52,342 |
| 2025-03-31 | $50,857 |
| 2024-12-31 | $49,550 |
| 2024-09-30 | $51,305 |
| 2024-06-30 | $49,902 |
| 2024-03-31 | $53,447 |
| 2023-12-31 | $53,490 |
| 2023-09-30 | $52,415 |
| 2023-06-30 | $51,724 |
| 2023-03-31 | $51,486 |
| 2022-12-31 | $50,090 |
| 2022-09-30 | $46,993 |
| 2022-06-30 | $46,601 |
| 2022-03-31 | $46,362 |
| 2021-12-31 | $45,177 |
| 2021-09-30 | $43,461 |
| 2021-06-30 | $42,766 |
| 2021-03-31 | $40,430 |
| 2020-12-31 | $39,777 |
| 2020-09-30 | $37,973 |
| 2020-06-30 | $36,273 |
| 2020-03-31 | $31,066 |
| 2019-12-31 | $30,282 |
| 2019-09-30 | $33,196 |
| 2019-06-30 | $32,213 |
| 2019-03-31 | $31,569 |
| 2018-12-31 | $28,227 |
| 2018-09-30 | $27,685 |
| 2018-06-30 | $27,224 |
| 2018-03-31 | $27,202 |
| 2017-12-31 | $26,368 |
| 2017-09-30 | $25,381 |
| 2017-06-30 | $24,595 |
| 2017-03-31 | $23,791 |
| 2016-12-31 | $23,077 |
| 2016-09-30 | $23,264 |
| 2016-06-30 | $25,120 |
| 2016-03-31 | $24,577 |
| 2015-12-31 | $23,764 |
| 2015-09-30 | $23,184 |
| 2015-06-30 | $24,172 |
| 2015-03-31 | $23,391 |
| 2014-12-31 | $23,450 |
| 2014-09-30 | $23,810 |
| 2014-06-30 | $23,789 |
| 2014-03-31 | $23,029 |
| 2013-12-31 | $22,451 |
| 2013-09-30 | $21,371 |
| 2013-06-30 | $20,365 |
| 2013-03-31 | $19,749 |
| 2012-12-31 | $19,084 |
| 2012-09-30 | $18,953 |
| 2012-06-30 | $18,368 |
| 2012-03-31 | $17,891 |
| 2011-12-31 | $16,972 |
| 2011-09-30 | $16,562 |
| 2011-06-30 | $16,556 |
| 2011-03-31 | $14,724 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $150.156B | $24.568B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $120.821B | 19.12 |
| CVS Health (CVS) | United States | $99.843B | 11.63 |
| Elevance Health (ELV) | United States | $76.540B | 11.49 |
| Cencora (COR) | United States | $70.193B | 22.08 |
| Natera (NTRA) | United States | $28.526B | 0.00 |
| Labcorp Holdings (LH) | United States | $23.430B | 17.86 |
| DiDi Global (DIDIY) | China | $21.650B | 20.00 |
| Viatris (VTRS) | United States | $18.163B | 6.77 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $15.306B | 0.00 |
| BioMerieux (BMXMF) | France | $13.324B | 0.00 |
| Solventum (SOLV) | United States | $13.104B | 12.72 |
| Medpace Holdings (MEDP) | United States | $12.148B | 27.98 |
| Revvity (RVTY) | United States | $10.887B | 18.94 |
| CochLear (CHEOY) | Australia | $9.243B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.941B | 15.29 |
| ICON (ICLR) | Ireland | $7.510B | 7.45 |
| Sonic Healthcare (SKHHY) | Australia | $7.449B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $7.008B | 41.78 |
| HealthEquity (HQY) | United States | $6.312B | 23.60 |
| Avantor (AVTR) | United States | $6.275B | 10.11 |
| Bausch + Lomb (BLCO) | Canada | $6.034B | 39.60 |
| PACS (PACS) | United States | $5.922B | 36.01 |
| Caris Life Sciences,�Inc (CAI) | United States | $5.818B | 0.00 |
| Sotera Health (SHC) | United States | $4.864B | 23.45 |
| Alignment Healthcare (ALHC) | United States | $4.040B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.532B | 20.61 |
| Concentras Parent (CON) | United States | $3.017B | 18.83 |
| GeneDx Holdings (WGS) | United States | $2.606B | 45.76 |
| Establishment Labs Holdings (ESTA) | United States | $2.168B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.000B | 25.77 |
| Organon (OGN) | United States | $1.921B | 2.15 |
| Pediatrix Medical (MD) | United States | $1.848B | 11.04 |
| Progyny (PGNY) | United States | $1.784B | 35.07 |
| Ardent Health (ARDT) | United States | $1.375B | 4.49 |
| InnovAge Holding (INNV) | United States | $1.134B | 167.20 |
| CareDx (CDNA) | United States | $1.010B | 16.50 |
| Teladoc Health (TDOC) | United States | $0.825B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.740B | 12.11 |
| Nutex Health (NUTX) | United States | $0.705B | 5.39 |
| Omada Health (OMDA) | United States | $0.655B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.641B | 0.00 |
| Embecta (EMBC) | United States | $0.602B | 3.36 |
| Enhabit (EHAB) | United States | $0.565B | 25.36 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.558B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.478B | 8.79 |
| CryoPort (CYRX) | United States | $0.418B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.396B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.391B | 82.38 |
| Auna S.A (AUNA) | Luxembourg | $0.367B | 5.90 |
| So-Young (SY) | China | $0.328B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.247B | 0.00 |
| Agilon Health (AGL) | United States | $0.150B | 0.00 |
| LifeMD (LFMD) | United States | $0.134B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.091B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.078B | 0.00 |
| DocGo (DCGO) | United States | $0.073B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.041B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.039B | 0.00 |
| Pomdoctor - (POM) | China | $0.026B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.018B | 5.62 |
| OSR Holdings (OSRH) | United States | $0.013B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.012B | 0.00 |
| Lifeward (LFWD) | United States | $0.009B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |